Bioactive Ingredients Market Analysis, Demand And Growth 2025 - 2034


Developed by experienced analysts, this report offers in-depth insights for understanding competition and customer behavior in the bioactive ingredients industry.

Bioactive Ingredients Market Analysis & Forecast: 2025-2029
The bioactive ingredients market size has grown strongly in recent years. It will grow from $48.8 billion in 2024 to $52.14 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to health consciousness, rising incidence of chronic diseases, expanding aging population, increased demand for natural products, expansion of functional foods and beverages.

The bioactive ingredients market size is expected to see strong growth in the next few years. It will grow to " $71.74 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing focus on immune health, rising demand for plant-based products, expanding beauty and cosmetics industry, nutraceuticals and functional supplements market growth, global sustainable and ethical practices. Major trends in the forecast period include rising consumer awareness and demand for functional foods, expanding applications in nutraceuticals and dietary supplements, focus on natural and plant-based sources, innovations in extraction and processing technologies, health and wellness as a lifestyle.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10045&type=smp

What Are The Factors Driving The Bioactive Ingredients Market?
Increasing adoption of organic and natural ingredients is expected to propel the growth of the bioactive ingredients market going forward. Ingredients that are derived from nature and manufactured without synthetic chemicals or genetically modified organisms (GMOs) are referred to as organic and natural ingredients. Customers have become more aware of the possible health benefits of natural and organic chemicals, and many products include these ingredients. Since bioactive compounds are derived from natural sources and typically marketed as organic or natural, they appeal to health-conscious clients. For instance, in February 2023, according to The Soil Association Certification's Organic Market Report 2023, the UK's organic market surged to a record value of £3.1 billion, marked by a 1.6% sales growth in 2022. This increase indicates a daily expenditure of nearly £8.5 million on organic products by consumers in the UK. Therefore, the increasing adoption of organic and natural ingredients is driving the growth of the bioactive ingredients market.

What Segments Are Covered In The Bioactive Ingredients Market Report?
The bioactive ingredientsmarket covered in this report is segmented –

1) By Product: Fiber, Vitamins, Omega 3 PUFA, Plant Extracts, Minerals, Carotenoids And Antioxidants, Probiotics, Other Products
2) By Source: Plant, Animal, Microbial
3) By Application: Functional Food And Beverage, Dietary Supplements, Clinical Nutrition, Personal Care, Other Applications

Subsegments:
1) By Fiber: Soluble Fiber, Insoluble Fiber
2) By Vitamins: Water-Soluble Vitamins, Fat-Soluble Vitamins
3) By Omega 3 PUFA: EPA (Eicosapentaenoic Acid), DHA (Docosahexaenoic Acid)
4) By Plant Extracts: Herbal Extracts, Phytochemicals
5) By Minerals: Macro Minerals, Trace Minerals
6) By Carotenoids And Antioxidants: Carotenoids, Polyphenols
7) By Probiotics: Lactobacillus, Bifidobacterium
8) By Other Products: Enzymes, Peptides

What Are The Main Trends, Positively Impacting The Growth Of Bioactive Ingredients Market?
Product innovations are a key trend gaining popularity in the bioactive ingredients market. Major companies operating in bioactive ingredients are developing innovative products to sustain their position in the market. For instance, in April 2022, Demetrix, Inc., a US-based biotechnology business that specializes in developing and manufacturing bioactive compounds, announced the commercial-scale launch of a novel bioactive component, Arete-G, which is the company's proprietary CBG, and a rare cannabinoid present in the cannabis sativa plant. In vitro experiments using the Chorioallantoic Membrane Vascular Assay (CAMVA) and the Bovine Corneal Opacity and Permeability (BCOP) assay were used to assess CBG for eye discomfort. Neither of the CBG formulations examined (1% CBG cream or 10% CBG in caprylic/capric triglyceride) was found to be an irritant in the BCOP assay or CAMVA.

Which Are The Major Players Operating In The Global Bioactive Ingredients Market?
Major companies operating in the bioactive ingredients market include Sabinsa Corporation, Archer Daniels Midland Company (ADM), BASF SE, Cargill Incorporated, Ajinomoto Co. Inc., DuPont de Nemours Inc., Roquette Frères, Owen Biosciences Inc., Sensient Technologies, Nuritas Ltd., Kerry Group plc, Royal FrieslandCampina N.V., Chr. Hansen A/S, Neptune Wellness Solutions Inc., Evonik Industries AG, Royal DSM N.V., Ingredion Incorporated, Tate & Lyle plc, FMC Corporation, Givaudan SA, Symrise AG, International Flavors & Fragrances Inc., Ashland Global Holdings Inc., Corbion N.V., Lonza Group AG, Novozymes A/S, Bioiberica S.A., Nexira SAS, Kemin Industries Inc., Naturex S.A., Indena S.p.A., Martin Bauer Group, Frutarom Industries Ltd., RFI Ingredients LLC, FutureCeuticals Inc., Beijing Gingko Group, Nutraceutical International Corporation, Bio-Botanica Inc.

View the full bioactive ingredients market report here:
https://www.thebusinessresearchcompany.com/report/bioactive-ingredients-global-market-report

Bioactive Ingredients Market Regional Insights:
North America was the largest region in the bioactive ingredients market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global bioactive ingredients market report forecast period. The regions covered in the bioactive ingredients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more